Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

Babak Baban, Phillip Chandler, Doris McCool, Brendan Marshall, David H. Munn, Andrew L. Mellor

Research output: Contribution to journalArticle

216 Citations (Scopus)

Abstract

Pharmacologic inhibition of indoleamine 2,3 dioxygenase (IDO) activity during murine pregnancy results in rejection of allogeneic fetuses by the maternal immune system. Here, we show that IDO expression is restricted to perinuclear regions of primary trophoblast giant cells (TGCs) of fetal origin at mid-gestation (E10.5). After placentation (E14), no IDO expression was detected at the maternal-fetal interface. Matings involving IDO-deficient females revealed that paternally inherited IDO alleles were inactive in primary TGCs, presumably due to paternal genome-specific gene inactivation. Allogeneic matings in which both parents were genetically IDO-deficient produced litters of normal sizes at normal rates compared to IDO-sufficient parental mice, implying that compensatory or redundant immunosuppressive mechanisms protected allogeneic fetuses during gestation in IDO-deficient mice. Consistent with this notion, treatment with IDO inhibitor did not affect allogeneic pregnancy rates when both parents were IDO-deficient, confirming that IDO was the relevant pharmacologic target of the IDO inhibitor in matings involving IDO-sufficient mice. Hence, IDO is a key immunosuppressive mechanism in normal murine pregnancies, and it is regulated entirely through maternally inherited fetal genes.

Original languageEnglish (US)
Pages (from-to)67-77
Number of pages11
JournalJournal of Reproductive Immunology
Volume61
Issue number2
DOIs
StatePublished - Apr 1 2004

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
Trophoblasts
Giant Cells
Mothers
Genome
Pregnancy
Immunosuppressive Agents
Fetus
Placentation
Litter Size
Gene Silencing
Pregnancy Rate

Keywords

  • IDO
  • Immunohistochemistry
  • Placenta
  • Tolerance
  • Trophoblast giant cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. / Baban, Babak; Chandler, Phillip; McCool, Doris; Marshall, Brendan; Munn, David H.; Mellor, Andrew L.

In: Journal of Reproductive Immunology, Vol. 61, No. 2, 01.04.2004, p. 67-77.

Research output: Contribution to journalArticle

@article{b9ed6c0da6be4f739c1d4ef360973a87,
title = "Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific",
abstract = "Pharmacologic inhibition of indoleamine 2,3 dioxygenase (IDO) activity during murine pregnancy results in rejection of allogeneic fetuses by the maternal immune system. Here, we show that IDO expression is restricted to perinuclear regions of primary trophoblast giant cells (TGCs) of fetal origin at mid-gestation (E10.5). After placentation (E14), no IDO expression was detected at the maternal-fetal interface. Matings involving IDO-deficient females revealed that paternally inherited IDO alleles were inactive in primary TGCs, presumably due to paternal genome-specific gene inactivation. Allogeneic matings in which both parents were genetically IDO-deficient produced litters of normal sizes at normal rates compared to IDO-sufficient parental mice, implying that compensatory or redundant immunosuppressive mechanisms protected allogeneic fetuses during gestation in IDO-deficient mice. Consistent with this notion, treatment with IDO inhibitor did not affect allogeneic pregnancy rates when both parents were IDO-deficient, confirming that IDO was the relevant pharmacologic target of the IDO inhibitor in matings involving IDO-sufficient mice. Hence, IDO is a key immunosuppressive mechanism in normal murine pregnancies, and it is regulated entirely through maternally inherited fetal genes.",
keywords = "IDO, Immunohistochemistry, Placenta, Tolerance, Trophoblast giant cells",
author = "Babak Baban and Phillip Chandler and Doris McCool and Brendan Marshall and Munn, {David H.} and Mellor, {Andrew L.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1016/j.jri.2003.11.003",
language = "English (US)",
volume = "61",
pages = "67--77",
journal = "Journal of Reproductive Immunology",
issn = "0165-0378",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

AU - Baban, Babak

AU - Chandler, Phillip

AU - McCool, Doris

AU - Marshall, Brendan

AU - Munn, David H.

AU - Mellor, Andrew L.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Pharmacologic inhibition of indoleamine 2,3 dioxygenase (IDO) activity during murine pregnancy results in rejection of allogeneic fetuses by the maternal immune system. Here, we show that IDO expression is restricted to perinuclear regions of primary trophoblast giant cells (TGCs) of fetal origin at mid-gestation (E10.5). After placentation (E14), no IDO expression was detected at the maternal-fetal interface. Matings involving IDO-deficient females revealed that paternally inherited IDO alleles were inactive in primary TGCs, presumably due to paternal genome-specific gene inactivation. Allogeneic matings in which both parents were genetically IDO-deficient produced litters of normal sizes at normal rates compared to IDO-sufficient parental mice, implying that compensatory or redundant immunosuppressive mechanisms protected allogeneic fetuses during gestation in IDO-deficient mice. Consistent with this notion, treatment with IDO inhibitor did not affect allogeneic pregnancy rates when both parents were IDO-deficient, confirming that IDO was the relevant pharmacologic target of the IDO inhibitor in matings involving IDO-sufficient mice. Hence, IDO is a key immunosuppressive mechanism in normal murine pregnancies, and it is regulated entirely through maternally inherited fetal genes.

AB - Pharmacologic inhibition of indoleamine 2,3 dioxygenase (IDO) activity during murine pregnancy results in rejection of allogeneic fetuses by the maternal immune system. Here, we show that IDO expression is restricted to perinuclear regions of primary trophoblast giant cells (TGCs) of fetal origin at mid-gestation (E10.5). After placentation (E14), no IDO expression was detected at the maternal-fetal interface. Matings involving IDO-deficient females revealed that paternally inherited IDO alleles were inactive in primary TGCs, presumably due to paternal genome-specific gene inactivation. Allogeneic matings in which both parents were genetically IDO-deficient produced litters of normal sizes at normal rates compared to IDO-sufficient parental mice, implying that compensatory or redundant immunosuppressive mechanisms protected allogeneic fetuses during gestation in IDO-deficient mice. Consistent with this notion, treatment with IDO inhibitor did not affect allogeneic pregnancy rates when both parents were IDO-deficient, confirming that IDO was the relevant pharmacologic target of the IDO inhibitor in matings involving IDO-sufficient mice. Hence, IDO is a key immunosuppressive mechanism in normal murine pregnancies, and it is regulated entirely through maternally inherited fetal genes.

KW - IDO

KW - Immunohistochemistry

KW - Placenta

KW - Tolerance

KW - Trophoblast giant cells

UR - http://www.scopus.com/inward/record.url?scp=1842507884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842507884&partnerID=8YFLogxK

U2 - 10.1016/j.jri.2003.11.003

DO - 10.1016/j.jri.2003.11.003

M3 - Article

C2 - 15063630

AN - SCOPUS:1842507884

VL - 61

SP - 67

EP - 77

JO - Journal of Reproductive Immunology

JF - Journal of Reproductive Immunology

SN - 0165-0378

IS - 2

ER -